Cargando…

Lung function in adult patients with cystic fibrosis after using the eFlow(® )rapid for one year

BACKGROUND: The new generation nebuliser PARI eFlow(® )rapid allows a highly efficient aerosol delivery at reduced inhalation time. However, lung function data during long-term use of this device are not available until now. METHODS: 70 clinically stable adult cystic fibrosis patients participated i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naehrig, S, Lang, S, Schiffl, H, Huber, RM, Fischer, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353423/ https://www.ncbi.nlm.nih.gov/pubmed/21463983 http://dx.doi.org/10.1186/2047-783X-16-2-63

Ejemplares similares

In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution
por: Pham, Stephen, et al.
Publicado: (2018)

Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer
por: Abd-Elaziz, Khalid, et al.
Publicado: (2020)

Comparison of NUCLEOCOUNTER, ANDROVISION with Leja chambers and the newly developed ANDROVISION eFlow for sperm concentration analysis in boars
por: Grossfeld, Rudolf, et al.
Publicado: (2022)

Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease
por: Pleasants, Roy A.
Publicado: (2018)

Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow(®) CS
por: Stephenson, Judith J, et al.
Publicado: (2020)

Extended Pharmacopeial Characterization of Surfactant Aerosols Generated by a Customized eFlow Neos Nebulizer Delivered through Neonatal Nasal Prongs
por: Bianco, Federico, et al.
Publicado: (2020)

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®
por: Ohar, Jill A., et al.
Publicado: (2020)

A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis
por: Khoo, Jun Keng, et al.
Publicado: (2020)

Dose selection for glycopyrrolate/eFlow(®) phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies
por: Donohue, James F., et al.
Publicado: (2017)

An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2020)

Long-term outcomes of survivors of ICU acute kidney injury requiring renal replacement therapy: a 10-year prospective cohort study
por: Schiffl, Helmut, et al.
Publicado: (2012)

Bone accrual and structural changes over one year in youth with cystic fibrosis
por: Bass, Rosara M., et al.
Publicado: (2022)

Lung Microbiome in Cystic Fibrosis
por: Scialo, Filippo, et al.
Publicado: (2021)

The Gut-Lung Axis in Cystic Fibrosis
por: Price, Courtney E., et al.
Publicado: (2021)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

Risk of lung cancer and renin–angiotensin blockade: a concise review
por: Rachow, Tobias, et al.
Publicado: (2020)

Viral infections of the respiratory tract in patients with cystic fibrosis
por: Przyklenk, B., et al.
Publicado: (1988)

How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old
por: Prados, C., et al.
Publicado: (2017)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis
por: Gonem, Sherif, et al.
Publicado: (2014)

Myocardial infarction in an adult with cystic fibrosis and heart and lung transplant
por: Eaden, James, et al.
Publicado: (2013)

Variation in lung function and clinical aspects in adults with cystic fibrosis
por: da Silva, Elias Aguiar, et al.
Publicado: (2022)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway
por: Jean-Pierre, Fabrice, et al.
Publicado: (2021)

High-volume online haemodiafiltration treatment and outcome of end-stage renal disease patients: more than one mode
por: Schiffl, Helmut
Publicado: (2020)

A Developmental Role of the Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Lung Disease Pathogenesis
por: Huang, Elena N., et al.
Publicado: (2021)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
por: Harwood, Kiera H., et al.
Publicado: (2021)

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes
por: Yadav, Ruchi, et al.
Publicado: (2023)

Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
por: Carbone, Annalucia, et al.
Publicado: (2023)

Bacterial activity in cystic fibrosis lung infections
por: Rogers, Geraint B, et al.
Publicado: (2005)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

Ecological networking of cystic fibrosis lung infections
por: Quinn, Robert A, et al.
Publicado: (2016)

Lung function and microbiota diversity in cystic fibrosis
por: Cuthbertson, Leah, et al.
Publicado: (2020)

Gene therapy for cystic fibrosis lung disease
por: Sumner-Jones, Stephanie G., et al.
Publicado: (2011)

Cystic Fibrosis Lung Disease in the Aging Population
por: Künzi, Lisa, et al.
Publicado: (2021)

Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung
por: Planet, Paul J
Publicado: (2022)

Results of Lung Transplantation for Cystic Fibrosis With Selected Donors Over 65 Years Old
por: Glorion, Matthieu, et al.
Publicado: (2023)

Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation: a survey of Italian CF centers
por: Borchi, Beatrice, et al.
Publicado: (2018)

Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2023)

Infection prevention and control in cystic fibrosis: One size fits all?
por: Lands, Larry C.
Publicado: (2020)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_dh8l60jtk0qdi1vqijlqj5f8fg